Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 8Recruiting 3Unknown 1Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Pain 1Neoplasms 1Marijuana Abuse 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Dronabinol × Clear all
NCT06731894 2025-12-05

Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

City of Hope Medical Center

Phase 2 Recruiting
120 enrolled
BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms

NCT06601218 2025-06-24

Impact of Daily Oral Cannabis Doses in Patients With Cancer

University of Kentucky

Phase 1 Recruiting
80 enrolled

Neoplasms, Pain

NCT06518434 2024-07-24

CanHep

University Medical Center Groningen

Phase 2 Recruiting
20 enrolled
Gastrointestinal

Marijuana Abuse, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡